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Abstract 24 
While intense endurance and resistance exercise training and whey protein supplementation 25 
have both been shown to independently improve glycaemic control, no known studies have 26 
examined the effect of high-intensity mixed-mode interval training (MMIT) and whey 27 
supplementation in adults with Type-2 diabetes (T2D). 28 
Purpose: To determine if peri-training whey protein supplementation combined with MMIT 29 
can improve glycaemic control. 30 
Methods: In a double-blind randomised controlled trial, 24 men (55.7±5.6 y) with T2D 31 
performed MMIT with whey (20 grams) or placebo control for 10 weeks. Glycaemic control 32 
was assessed via glucose disposal rate (GDR) during a euglycaemic insulin clamp, fasting 33 
blood glucose concentration (FBG), and HOMA-IR. Changes in peak oxygen consumption 34 
(VO2peak), 1-repetition maximum strength (1RM), Vastus lateralis (VL) muscle and 35 
subcutaneous adipose thicknesses (SAT), and waist circumference (WC) were also assessed.  36 
Results: 10-weeks of MMIT substantially improved GDR by 27.5% (90%CI 1.2%, 60.7%) 37 
and 24.8% (-5.4%, 64.8%) in the whey and control groups, respectively. There were likely 38 
and possible reductions in FBG by -17.4% (-30.6%, -1.6) and HOMA-IR by -14.1% (-25.3%, 39 
1.08%) in the whey group, however, whey effects were not clearly beneficial to glycaemic 40 
outcomes, relative to control. MMIT also clearly substantially improved 1RM by 20.6% 41 
(16.3%, 24.9%) and 22.7% (18.4%, 27.2%), VO2peak by 22.6% (12.0%, 26.2%) and 18.5% 42 
(10.5%, 27.4%), VL muscle thickness by 18.9% (12.0%, 26.2%) and 18.6% (10.5%, 27.4%) 43 
and possibly reduced WC by -2.1% (-3.1%, -1.0%) and -1.9% (-3.7%, -0.1%) in the control 44 
and whey groups respectively, but the whey-control outcome was trivial or unclear.  45 
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Conclusion: A clinically-meaningful enhancement in glycaemic control following 10-46 
weeks of MMIT was not clearly advanced with peri-training whey protein supplementation in 47 
middle-aged men with Type-2 diabetes.   48 
Key Words: Milk-protein, exercise, diabetes, interval training, high-intensity, glucose 49 
disposal.  50 
Introduction 51 
A central pathology of type-2 diabetes (T2D) is impaired glycaemic control, a 52 
condition characterised by a diminished capacity to restore postprandial blood glucose 53 
concentrations to homeostatic levels. Skeletal muscle is the major tissue of postprandial 54 
glucose disposal (1), and a well-established site of dysfunction in T2D (2). It is well-55 
documented that T2D skeletal muscle displays low expression of proteins contributing to 56 
glucose uptake and metabolism, including: contractile, glucose transporter, and mitochondrial 57 
proteins (3-5). Exercise has been shown to upregulate the expression of these proteins (6, 7), 58 
and it is well-established that the improvements in aerobic capacity, lean mass and strength 59 
that follow progressive aerobic or circuit resistance training are also associated with better 60 
glycaemic control (8, 9). High-intensity interval training has emerged as an effective low-61 
volume and time-efficient exercise mode for rapidly improving glycaemic control. In middle-62 
aged men with T2D, 2 weeks of high-intensity cycle interval training was shown to 63 
significantly increase the expression of glucose transporter 4 (GLUT4) and mitochondrial 64 
proteins in the vastus lateralis muscle and lower 24-hour blood glucose concentrations (6).  65 
Milk protein supplementation has shown promise as a complementary therapeutic 66 
agent to exercise for improving glycaemic control. Milk proteins are rich in amino acids that 67 
stimulate protein synthesis in skeletal muscle (10), which may, like exercise training, lead to 68 
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better glycaemic control. Independently, whey supplementation was shown to improve 69 
glucose tolerance and FBG after 8 weeks in insulin resistant rats (11, 12) and HOMA-IR after 70 
12 weeks in overweight and obese adults (13). As an adjunct therapy to exercise and 71 
compared to carbohydrate consumption alone, milk-protein supplementation for 6 weeks was 72 
reported to improve VO2max in treadmill trained sedentary men (14) and lean mass and 1RM 73 
bench press strength after 8 weeks in mixed-mode trained female college basketball players 74 
(15). As each of those outcomes has been previously associated with improved glycaemic 75 
control (9, 16, 17) combined treatments may also provide better therapeutic outcomes than 76 
exercise alone in populations with T2D. 77 
The aim of this study was to determine whether whey supplementation for 10 weeks 78 
would improve glycaemic control in a population with T2D performing high-intensity mixed-79 
mode interval training. We hypothesised that whey supplementation would enhance 80 
glycaemic control to a greater extent than exercise alone. If effective, this may provide a 81 
practical adjunct therapy to exercise for improving T2D rehabilitation outcomes.  82 
 83 
Methods 84 
Participants 85 
Men with T2D (n=24) were recruited from local medical centres in Wellington, NZ. 86 
Inclusion characteristics were age 40-65 y, BMI<40, not requiring insulin therapy, and not 87 
meeting the ACSM guidelines for exercise for T2D (18). Ethics was approved by the 88 
Northern B Health and Disability Ethics Committee, Ministry of Health, Wellington NZ 89 
(13/NTB/69). Participants provided written informed consent. 90 
 91 
Experimental Design 92 
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The design was a double blind, randomized (Research Randomizer, Version 4.0, 93 
http://www.randomizer.org), placebo controlled trial (http://www.anzctr.org.au/, Registration 94 
number ACTRN12613000340730). At early stages of data collection, the original intended 95 
third group: whey without MMIT, was removed from the study design because recruited 96 
eligible participants declined to participate if not randomised to an exercise group creating 97 
sampling bias. In the two-group design, participants consumed a whey-protein beverage or 98 
carbohydrate placebo before and after 45 early-morning MMIT sessions over 10 weeks. 99 
Participants were encouraged to maintain dietary and medication habits throughout the 100 
experimental period and not to participate in strenuous activity within 2 days of testing 101 
sessions. Participants were familiarised with all testing procedures except the euglycaemic 102 
insulin clamp prior to baseline testing. Cardiac screening via ECG was performed at 103 
familiarisation during a VO2peak cycling test. Baseline testing occurred 5-10 days prior to 104 
commencement of the intervention with post-testing 2 days after 45 exercise sessions. The 105 
post glucose clamp was performed 48 hours after maximal cycling and strength tests to 106 
provide a washout period that would allow for the bulk of the acute effects of intense exercise 107 
on glycaemia to return to pre-exercise levels without inducing a period of deconditioning (19, 108 
20).  109 
 110 
Exercise Protocol 111 
Participants completed 27 cycling and 18 resistance training sessions (4-5 sessions each 112 
week). Sessions included a 5-minute warm-up at low intensity on a cycle ergometer or 113 
rowing machine followed by 20 minutes of 1-minute interval style cycling or resistance 114 
exercise. Pre-programmed cycling sessions (VeloTron Racer Mate, Seattle, WA) included 10 115 
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intervals at 70%-90% (increased 5% every 2 weeks) of the participants’ peak oxygen 116 
consumption volume (VO2peak) obtained from baseline and fortnightly cycle testing 117 
(SensorMedics Vmax, YorbaLinda, CA), with 1-minute active recovery intervals at 40% of 118 
peak workload. Resistance training included 5 sets of 30 repetitions of each exercise (Day 1: 119 
bench press and seated rows), and (Day 2: lateral pulldowns and barbell upright rows) with 1 120 
minute of crunches on a fitball (Hart Sport, Auckland, NZ) as active recovery. Intensity was 121 
set at 20% of 1-repetition maximum (1RM) during weeks 1-2 and increased to 25% of 1RM 122 
to elicit a high-intensity workload, for the remainder of the intervention based upon baseline 123 
and fortnightly testing. If participants were unable to maintain a set cycling or strength 124 
workload for a full minute the subsequent interval was reduced by 10%. All exercise and 125 
testing sessions were supervised by the researchers. 126 
 127 
Supplement 128 
Participants appeared each morning to the exercise laboratory in a fasted state. A chocolate 129 
flavoured whey protein isolate (WPI-895, Fonterra, Auckland, New Zealand) beverage (20 130 
grams protein/10 grams carbohydrate/3 grams milk-fat) or an identically-flavoured but non-131 
protein formulated isocaloric beverage (30 grams carbohydrate/3 grams milk-fat) was 132 
consumed immediately before and after each exercise session. Each drink contained 175 133 
calories (731 kilojoules). To reduce hunger and provide opportunity for a clear peri-training 134 
whey compared to carbohydrate consumption effect to be observed, each participant 135 
consumed a low-protein snack bar (Nature Valley, General Mills, Auckland, NZ) 1 hour after 136 
exercise and resumed normal eating habits after 2 hours. 137 
 138 
Glycaemic Measures 139 
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Glucose disposal rate (GDR) for each individual was determined via a modified euglycaemic 140 
insulin clamp as described previously (21). Briefly, participants appeared for testing between 141 
7 and 9 am after an overnight fast and at least 48 hours after the last exercise testing session. 142 
A catheter was placed at the antecubital vein for insulin and glucose infusion, and dorsally at 143 
the hand for blood draws. Arterialised blood was obtained by placing the hand in a heater box 144 
at 50 °C. Participants received priming insulin doses of 160 mU·m2·min-1 for 4 minutes and 145 
80 mU·m2·min-1 for 3 minutes, after which the dosage was reduced to 40 mU·m2·min-1 for 146 
the remainder of the clamp. A 25% glucose infusion was initiated at 15 minutes or sooner if 147 
fasting blood glucose levels were below 6.5 mmol·L-1and adjusted after 5-minute blood 148 
glucose readings until stabilised at 5 mmol·L-1. As this method elevated blood insulin 149 
concentrations within a physiological rather than a supraphysiological range, the time to 150 
stabilisation was variable between participants. GDR was calculated from the average rate of 151 
glucose infused (mg·kg-1·min-1) during a 60 minute stabilisation phase. Fasting blood 152 
samples were obtained to determine FBG and HOMA-IR.  153 
 154 
Physical Exercise Capacity 155 
Participants completed a continuous ramp protocol to volitional exhaustion on a cycle 156 
ergometer commencing at 40 Watts for 3 minutes and increasing 1 Watt every 4 seconds. 157 
Participants were encouraged to maintain a cadence of 70 rpm during the ramp. Peak oxygen 158 
consumption (mL·kg-1·min-1) was measured as the average of the highest 30-second 159 
consumption rate during the test. Acceptance of a maximal effort was dependent upon the 160 
participant achieving a maximal Borg Scale (1-20) rating and/or an RER>1.15. Estimated 1 161 
repetition-maximum (1RM) tests were completed at baseline and every 2 weeks for smith 162 
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machine bench press, lateral pulldown, seated row and barbell upright row during a maximal-163 
effort of 3-6 repetitions and predicted via the Brzycki Formula (22). 164 
 165 
Body Composition  166 
Body composition measures were taken in a fasted state prior to exercise testing. VL 167 
thickness and subcutaneous adipose tissue (SAT) were measured after lying supine for 15 168 
minutes via B-mode ultrasound (Terason T32000, Teratech Corp., Burlington, MA) using 169 
previously validated protocols (23, 24) modified to include measurement of SAT at the 170 
biceps and cross-section diameter at the VL muscle. Measurements were taken in a supine 171 
position after participants had been lying relaxed for 15 minutes and then analysed using 172 
ImageJ software (National Institute of Health, Bethesda, Maryland). SAT was determined 173 
from the sum of adipose thickness at 4 standard calliper sites: thigh, calf, biceps, and triceps 174 
and VL thickness from the maximal cross-sectional diameter measured at 1/3 the distance 175 
from the centre of the patella to the tubercle of the anterior superior iliac spine. 176 
 177 
Statistical Methods 178 
 Sample size estimation was based upon the primary outcome GDR using the test-179 
retest values reported by Defronzo et al (25) in a healthy adult population and upon sample 180 
size estimations for magnitude based clinical inference (26, 27). The typical error of 181 
measurement was doubled to allow for uncertainty in variability in a T2D population 182 
and n was increased by 10% to allow for potential dropouts, which brought the required 183 
sample to 24. The threshold for smallest worthwhile clinical change in GDR was 5.4% based 184 
upon the effect of 3 months of hypoglycaemic therapy (Metformin) on naïve Type-2 diabetics 185 
(28).   186 
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The effect of treatment and time on all dependent variables was estimated from mixed 187 
models (Proc Mixed, SAS Version 9.1; SAS Institute, Cary, NC). Data were log transformed 188 
prior to analysis. Total 1RM strength was expressed as the back log-transformed average of 4 189 
log-transformed lift scores. Uncertainty was presented as 90% confidence limits or P value. 190 
Magnitude-based inference was employed to infer clinical and mechanistic outcome effects 191 
(27, 29). The probability that a contrast was at least greater than the clinical threshold or 192 
smallest Cohen’s d standardized difference (0.2  baseline SD) was: 25-75% possible, 75-193 
95% likely, 95-99.5% very likely, >99.5% almost certain (27). In the case where the majority 194 
(>50%) of the CI lay between the thresholds for positive and negative substantiveness, the 195 
effect was qualified trivial (negligible) with the respective probabilities as above (30). The 196 
terms benefit, trivial (negligible), and harm refer to the most likely directional outcome, 197 
relative to the smallest effect threshold. The terms unclear, inconclusive refers to outcomes 198 
where the likelihood of both benefit and harm exceeded 5%. The likelihood of a clinical 199 
benefit of intervention was expressed as the benefit:harm odds ratio, with 66:1 the smallest 200 
adoption threshold (27). Pre- and post-intervention scores are presented in figures as raw 201 
means and standard deviations.  202 
 203 
Results 204 
Twenty-four men with T2D were recruited to the study (Figure 1). There were no 205 
clear differences between group characteristics at baseline (Table 1). All participants 206 
completed the 45 exercise sessions within the 10-week period. The glycaemic control 207 
outcomes and statistical summary for all parameter measures are in Figure 2 and Table 2, 208 
respectively. Ten weeks of MMIT produced a clinically meaningful enhancement in GDR in 209 
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the whey and control groups, respectively, relative to the smallest threshold change (5.4%); 210 
however, the whey-control difference was unclear. The secondary outcome measures of 211 
glycaemic control (FBG and HOMA-IR) showed a likely and possible benefit of whey 212 
supplementation on FBG, and possible and unclear benefits on HOMA-IR in the whey and 213 
control groups respectively, reaching the adoption threshold (OR>66:1) only in the Whey 214 
group; however, there was also no clear difference in the Whey-Control contrast. Very likely 215 
and almost certain improvements in VO2peak, 1RM strength and VL muscle thickness in 216 
response to 10-weeks of MMIT in both the Whey and Control groups were observed (Figure 217 
3), but the whey-control differences were also negligible and unclear. There was a possible 218 
decrease in WC in both groups and a possible decrease in SAT in the whey group only (Table 219 
2).  220 
 221 
Discussion 222 
The current study showed that consumption of 20 grams of whey protein before and 223 
after MMIT for 10 weeks did not enhance glycaemic control in a T2D population assessed 224 
via measures of glucose disposal rate, fasting blood glucose, and HOMA-IR. Similarly, whey 225 
supplementation did not enhance any of the exercise performance adaptations accruing in 226 
response to MMIT, including VO2peak, 1RM strength, and muscle thickness. While previous 227 
evidence indicates that whey supplementation and high-intensity interval training 228 
independently improve glycaemic control (6, 13), no clear benefit of combined therapies was 229 
observed. 230 
Previously, consumption of 10 grams of whey protein hydrolysate before and after 231 
resistance training for 10 weeks was shown to significantly increase quadriceps cross-232 
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sectional area in healthy trained men (31). In addition, consumption of a single-dose of a 233 
mixed milk-protein (20 grams) carbohydrate beverage after treadmill training for 6 weeks 234 
significantly increased VO2max in sedentary middle-aged men compared to an isocaloric 235 
carbohydrate control (14). As both the increase in mid-thigh muscle cross-sectional area and 236 
VO2peak following exercise intervention have been previously associated with improved 237 
HbA1c in populations with Type-2 diabetics (9, 17), we predicted that peri-training whey 238 
supplementation for 10 weeks would lead to better glycaemic control than the MMIT alone. 239 
Our observation that whey supplementation did not clearly increase muscle thickness at the 240 
VL or VO2peak suggests that adaptive responses previously seen in exercising healthy 241 
populations may be lost with the development of T2D and may explain why we saw no effect 242 
of whey protein on GDR, FBG or HOMA-IR.  243 
It is possible that adults with T2D require a larger dose of milk-protein to induce 244 
clinically meaningful outcomes. 20 grams of protein has been reported to be the optimal 245 
dosage for improving protein synthetic responses in the skeletal muscle of healthy young men 246 
(32). While we also provided a total of 40 g of protein as 20 g before and 20 g after MITT, in 247 
another study in healthy elderly individuals (71±4 y), 40 grams of whey protein increased 248 
muscle protein synthesis after resistance training compared to a 20 gram dose (33). The 249 
cohort in the current study was middle-aged (55.6±5.7 y), however, T2D skeletal muscle has 250 
been shown to display characteristics of aged tissue, including: accelerated muscle wasting 251 
(34); lower contractile strength to muscle volume (35), and decreased mitochondrial density 252 
(36). Future investigations should test dosage effects on muscle protein synthetic responses in 253 
a population with T2D.  254 
While we saw no clear benefits of whey supplementation on glycaemic control in this 255 
study, there was some evidence that the protein exposure produced a more pronounced effect 256 
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on each of the glycaemic measures compared to exercise alone, as suggested through the 257 
observation of a substantially larger clinically-beneficial odds ratios for GDR, FBG, and 258 
HOMA-IR in the whey compared to the control group. We also observed that the adoption 259 
threshold (odds ratio >66) was reached for FBG, HOMA-IR and SAT only in the whey 260 
group, suggesting that the magnitude of the improvements in those secondary outcomes was 261 
sufficient to justify treatment use only when therapies were combined. It is important to 262 
acknowledge, however, that the full placebo-control adjusted outcome (whey-control), which 263 
takes into account the on-study effect, left a statistically unclear whey-protein effect. We 264 
suggest that a longer intervention or a larger cohort (to increase study power) may have 265 
clarified whether whey supplementation was enhancing the pattern for improvement in 266 
clinical outcomes.  267 
An inherent potential confounder of investigations with control of energy intake was 268 
that the control group was consuming substantially more carbohydrate each training morning 269 
than the whey group (60 compared to 20 grams). We reasoned that while there was potential 270 
for the control group to be consuming more carbohydrate than their normal dietary intake, 271 
which could be deleterious to glycaemic control, we expected that the metabolic demands of 272 
20 minutes of MMIT would obviate any effect on post-exercise blood glucose concentration 273 
in a previously sedentary population. In addition, 6 x 20 minute sessions of high-intensity 274 
interval cycling was previously shown to significantly improve postprandial and 24-hour 275 
blood glucose regulation in middle-aged adults with T2D (6). Our findings confirm that 276 
chronic intense interval training is effective for improving glycaemic control in populations 277 
with T2D. We also found that the 5-days per week, mixed-mode training regime was well-278 
adhered to by a previously sedentary, middle-aged T2D population, improved glucose 279 
disposal rates by a 4-5-fold greater magnitude than an equivalent duration of 280 
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pharmacotherapy (Metformin) alone (28), and negated the potentially deleterious impact of 281 
consuming 2  30 grams of a carbohydrate beverage each morning. Therefore, the MMIT 282 
mode of exercise training may prove to be highly effective for improving T2D health 283 
outcomes in long-term rehabilitation programs where high intensity exercise is appropriate.  284 
In conclusion, consumption of 20 grams of whey protein before and after high-285 
intensity mixed-mode interval training for 10 weeks, compared to isocaloric non-protein 286 
control, did not clearly enhance glycaemic control, VO2peak, 1RM strength, or VL muscle 287 
cross-section diameter in middle-aged men with T2D. These findings suggest that over short-288 
term interventions, populations with T2D may be resistant to nutritional stimulation of this 289 
nature. However, recent dose response data, and patterns for greater gains in some clinical 290 
parameters in the whey group support further investigation of the nutritional intervention, 291 
possibly increasing the supplement dose or the intervention period. 292 
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Figure 1. Recruitment flowchart. 407 
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Figure 2. Effect of 10 weeks of peri-training whey supplementation on: A) glucose disposal 409 
rate; B) fasting blood glucose concentration; and, C) HOMA-IR. Data are raw means and SD 410 
for the Pre (baseline) and Post testing time points. 411 
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Figure 3. Effect of 10 weeks of peri-training whey supplementation on: A) VO2peak; B) 1RM 413 
strength (the back log-transformed average of 4 log-transformed lift scores); and, C) vastus 414 
lateralis muscle thickness. Data are raw means and SD for the Pre (baseline) and Post testing 415 
time points. 416 
 417 
Table 1. Baseline characteristics of the 
Control and Whey groups. 
 Control Whey  
  n=12 n=12 
Parameter Mean SD Mean SD 
Age (y) 57.8 ± 5.2 53.5 ± 5.6 
Height (cm) 174.6 ± 7.1 177.1 ± 8.7 
Weight (kg) 91.9 ± 15.5 92.8 ± 11.0 
BMI (kg·m2) 30.1 ± 4.9 29.6 ± 2.7 
VO2peak (mL·kg-1·min-1) 26.9 ± 10.2 28.7 ± 4.9 
FBG (mmol·L-1) 9.4 ± 2.9 10.2 ± 3.6 
GDR (mg·kg-1·L-1) 2.11 ± 1.4 1.93 ± 0.8 
Time to euglycaemia (min) 106.3 ± 67.2 106.7 ± 53.9 
Data are presented as means and standard deviations. 
 
 418 
Table 2. The effect of 10-weeks peri-training whey-protein supplementation on established 
clinical measures of glycaemic control, exercise performance, and body composition. 
 
Contrasta % 
Change 
Upper 
CI 
Lower 
CI 
 
Likelihood (%) 
benefit/trivial/harmb 
Qualitativeb Benefit 
oddsb 
Glucose Disposal Rate 
Control 24.8 64.8 -5.4  90.1/7.1/2.8 Benefit likely 318 
Whey 27.5 60.7 1.2  95.6/3.5/0.9 Benefit very likely 2424 
Whey-Control 2.2 44.8 -28.0  42.6/24.4/33.0 Unclear 2 
Fasting Blood Glucose 
Control -8.1 10.7 -23.7  50.4/45.8/3.8 Benefit possible 26 
Whey -17.4 -1.6 -30.6  88.8/11.0/0.2 Benefit likely 3291 
Whey-Control -10 15.3 -29.8  57.3/35.9/6.8 Unclear 19 
HOMA-IR 
Control -5.3 28.3 -30.1  23.7/68.8/7.6 Unclear 4 
Whey -14.1 1.08 -25.3  42.0/58/0.0 Benefit possible 3331 
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Whey-Control 9.2 25.4 -34.2  35.0/59.1/6.0 Unclear 8 
VO2peak 
Control 22.6 26.2 12.0  99.8/0.2/0.0 Benefit almost certain 5.05E+07 
Whey 18.5 27.4 10.5  99.1/0.9/0.0  Benefit very likely 2.81E+06 
Whey-Control -3.3 9.07 -8.75  4.4/69.1/26.5 Trivial possible 0 
1-Repetition Maximum Strengthc 
Control 20.6 24.9 16.3  100/0.0/0.0 Benefit almost certain 3.29E+31 
Whey 22.7 27.2 18.4  100/0.0/0.0 Benefit almost certain 7.80E+35 
Whey-Control 1.8 7.1 -3.2  0.1/99.8/0.0 Trivial almost certain 11 
Muscle Thickness 
Control 18.9 26.2 12.0  100/0.0/0.0 Benefit almost certain 1.78E+09 
Whey 18.6 27.4 10.5  99.89/0.02/0.0 Benefit almost certain 6.62E+07 
Whey-Control -0.2 9.1 -8.8  13.6/70.6/15.9 Unclear 1 
Waist Circumference 
Control -2.1 -1.0 -3.1  41.0/59.1/0.0 Benefit possible 7.44E+05 
Whey -1.9 -0.1 -3.7  28.6/71.4/0.0 Benefit possible 2888 
Whey-Control 0.1 2.1 -1.8  0.3/99.5/0.2 Trivial very likely 2 
Subcutaneous Adipose Tissued 
Control -1 6.9 -8.3  6.7/90.8/2.5 Trivial likely 3 
Whey -6.9 3.5 -16.2  43.7/55.8/0.5 Benefit possible 151 
Whey-Control -6.0 6.7 -17.1  40.1/57.9/2.0 Benefit possible  32 
a Data for each contrast are post-pre. b The threshold for smallest clinical effect for glucose disposal rate was 5.4% 
(28); and for all other measures the smallest standardised difference (0.2xSD). The likelihood that a contrast was at 
least greater than the clinical threshold was: 25-75% possible, 75-95% likely, 95-99.5% very likely, >99.5% almost 
certain. Unclear refers to outcomes where the likelihood of both benefit and harm exceeded 5%.  The clinical 
adoption threshold was expressed as a benefit: harm odds ratio >66:1. c Total 1-Repetition Maximum strength was 
expressed as the back log-transformed average of 4 log-transformed lift scores. d Subcutaneous Adipose Tissue was 
expressed as the sum of 4 sites.  
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